{"id":"https://openalex.org/W7225649989","doi":"https://doi.org/10.3389/fphar.2026.1972185","title":"TACE plus systemic therapy in advanced hepatocellular carcinoma: a comparison of lenvatinib and donafenib","display_name":"TACE plus systemic therapy in advanced hepatocellular carcinoma: a comparison of lenvatinib and donafenib","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225649989","doi":"https://doi.org/10.3389/fphar.2026.1972185"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1972185","doi":"https://doi.org/10.3389/fphar.2026.1972185","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1972185","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1972185/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1972185/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161358061","display_name":"Hao Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hao Zhang","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161354572","display_name":"Ji-Hui Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji-Hui Hu","raw_affiliation_strings":["Department of Hepatobiliary, Breast & Thyroid, and Peripheral Vascular Surgery, The First People\u2019s Hospital of Loudi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary, Breast & Thyroid, and Peripheral Vascular Surgery, The First People\u2019s Hospital of Loudi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161310301","display_name":"Qing Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qing Wang","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161351668","display_name":"Bin Lan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Lan","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161343716","display_name":"Hao-Yu Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hao-Yu Yan","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027617236","display_name":"Zhi-Yong Fang","orcid":"https://orcid.org/0000-0002-0072-3415","observed_orcids":["https://orcid.org/0000-0002-0072-3415"]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhi-Yong Fang","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161323143","display_name":"Hua Xiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210115624","display_name":"Hunan Cancer Hospital","ror":"https://ror.org/025020z88","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210115624"]},{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hua Xiang","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University","Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210115624"]},{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100679090","display_name":"Jie Tan","orcid":"https://orcid.org/0000-0002-0909-2904","observed_orcids":["https://orcid.org/0000-0002-0909-2904","https://orcid.org/0000-0002-4311-4708"]},"institutions":[{"id":"https://openalex.org/I4210147389","display_name":"Hunan Provincial People's Hospital","ror":"https://ror.org/03wwr4r78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210147389"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jie Tan","raw_affiliation_strings":["Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Vascular Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University)","institution_ids":["https://openalex.org/I4210147389"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5027617236","https://openalex.org/A5100679090","https://openalex.org/A5161323143"],"corresponding_institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210115624","https://openalex.org/I4210147389"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9670000076293945},{"id":"https://openalex.org/keywords/donafenib","display_name":"donafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9259999990463257},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.9803000092506409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9103000164031982},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7609999775886536},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.7132999897003174},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.6891999840736389},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6733999848365784},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6518999934196472},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.6050000190734863},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4722000062465668},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.41909998655319214},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.41769999265670776},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.3828999996185303},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.3734999895095825},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3594000041484833},{"id":"https://openalex.org/C2778455285","wikidata":"https://www.wikidata.org/wiki/Q221788","display_name":"Transcatheter arterial chemoembolization","level":3,"score":0.34689998626708984},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3327000141143799},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.3190999925136566},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.2856999933719635},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.2849999964237213},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2587999999523163},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.2563999891281128},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1972185","doi":"https://doi.org/10.3389/fphar.2026.1972185","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1972185","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1972185/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1972185","doi":"https://doi.org/10.3389/fphar.2026.1972185","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1972185","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1972185/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322843","display_name":"Natural Science Foundation of\u00a0Hunan Province","ror":null},{"id":"https://openalex.org/F4320335777","display_name":"National Key Research and Development Program of China","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225649989.pdf","grobid_xml":"https://content.openalex.org/works/W7225649989.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1570622790","https://openalex.org/W2079586464","https://openalex.org/W2605668527","https://openalex.org/W2800499107","https://openalex.org/W2883286004","https://openalex.org/W2893608205","https://openalex.org/W2909659250","https://openalex.org/W2917680953","https://openalex.org/W2929062492","https://openalex.org/W2969802526","https://openalex.org/W3007074770","https://openalex.org/W3083679990","https://openalex.org/W3133722275","https://openalex.org/W3175451049","https://openalex.org/W3201703104","https://openalex.org/W3202374644","https://openalex.org/W3206566056","https://openalex.org/W4200218890","https://openalex.org/W4296334706","https://openalex.org/W4310046141","https://openalex.org/W4313529990","https://openalex.org/W4318045165","https://openalex.org/W4323057661","https://openalex.org/W4387214385","https://openalex.org/W4389055034","https://openalex.org/W4390581562","https://openalex.org/W4391014578","https://openalex.org/W4391686525","https://openalex.org/W4393935425","https://openalex.org/W4402581073","https://openalex.org/W4406160646","https://openalex.org/W4407805651","https://openalex.org/W4408462562","https://openalex.org/W4409487637","https://openalex.org/W4413168796","https://openalex.org/W4414830293","https://openalex.org/W4415836766","https://openalex.org/W4416305974","https://openalex.org/W4417427849","https://openalex.org/W7117304040","https://openalex.org/W7117966038","https://openalex.org/W7128073865","https://openalex.org/W7128204031","https://openalex.org/W7128304861","https://openalex.org/W7159997242","https://openalex.org/W7160017380"],"related_works":["https://openalex.org/W4402561108","https://openalex.org/W4388646382","https://openalex.org/W4400415495","https://openalex.org/W4381547213","https://openalex.org/W4400272967","https://openalex.org/W4387811171","https://openalex.org/W4392878325","https://openalex.org/W4289654165","https://openalex.org/W4400416814","https://openalex.org/W3154322879"],"abstract_inverted_index":{"Background":[0],"To":[1],"evaluate":[2],"transcatheter":[3],"arterial":[4],"chemoembolization":[5],"(TACE)":[6],"combined":[7,29,71,183,232],"with":[8,30,44,72,121,233,269],"systemic":[9,184,234],"therapy":[10,53,104,185,235,250],"versus":[11],"TACE":[12,31,58,68,231],"monotherapy":[13,59,114,207],"in":[14,240],"advanced":[15,45,241],"hepatocellular":[16],"carcinoma":[17],"(HCC),":[18],"and":[19,26,32,96,125,186,206,221,254,259],"to":[20,88,264],"compare":[21],"the":[22,133,136,154,219,248,265],"efficacies":[23],"of":[24,193,251],"lenvatinib":[25,73,155,220,255],"donafenib":[27,78,146,222],"when":[28],"immune":[33],"checkpoint":[34],"inhibitors":[35],"(ICIs).":[36],"Methods":[37],"This":[38],"retrospective":[39],"study":[40],"included":[41],"176":[42],"patients":[43],"HCC":[46,242],"receiving":[47],"initial":[48],"TACE,":[49,252],"categorized":[50],"into":[51],"combination":[52,138,205],"(n":[54,60,74,79],"=":[55,61,75,80,151,164,176,213,228],"128)":[56],"or":[57,77],"48)":[62],"groups.":[63],"A":[64],"subgroup":[65],"analysis":[66,179],"compared":[67,263],"plus":[69],"ICIs":[70],"78)":[76],"33).":[81],"Propensity":[82],"score":[83],"matching":[84],"(PSM)":[85],"was":[86],"utilized":[87],"minimize":[89],"baseline":[90],"confounding":[91],"variables.":[92],"Progression-free":[93],"survival":[94,98],"(PFS)":[95],"overall":[97],"(OS)":[99],"were":[100,202],"analyzed.":[101],"Results":[102],"Combination":[103],"achieved":[105],"a":[106,127,140,158,169,270],"significantly":[107,122,236],"higher":[108,141],"objective":[109,142],"treatment":[110,181,188],"effective":[111,143],"rate":[112,144],"than":[113,145],"(75.0%":[115],"vs.":[116,148,210,225],"41.7%,":[117],"P":[118,150,163,175,212,227],"<":[119],"0.001),":[120],"prolonged":[123],"PFS":[124,160,258],"OS,":[126],"benefit":[128],"maintained":[129,157],"after":[130],"PSM.":[131],"Among":[132],"specific":[134],"regimens,":[135],"lenvatinib-based":[137],"yielded":[139],"(83.3%":[147],"63.6%,":[149],"0.023).":[152],"Post-PSM,":[153],"group":[156],"significant":[159],"advantage":[161],"(":[162,174],"0.007),":[165],"while":[166],"OS":[167,273],"showed":[168],"marginal":[170],"trend":[171,271],"toward":[172,272],"improvement":[173,274],"0.057).":[177],"Multivariate":[178],"identified":[180],"without":[182,243],"ineffective":[187],"response":[189,261],"as":[190,215,217],"independent":[191],"predictors":[192],"inferior":[194],"OS.":[195],"Severe":[196],"TACE-related":[197],"adverse":[198],"events":[199],"(Grade":[200],"3/4)":[201],"comparable":[203],"between":[204,218],"cohorts":[208],"(18.8%":[209],"14.6%,":[211],"0.518),":[214],"well":[216],"subgroups":[223],"(21.8%":[224],"15.2%,":[226],"0.422).":[229],"Conclusion":[230],"improves":[237],"clinical":[238],"outcomes":[239],"increasing":[244],"severe":[245],"toxicity.":[246],"Furthermore,":[247],"triple":[249],"ICIs,":[253],"confers":[256],"superior":[257],"tumor":[260],"rates":[262],"donafenib-based":[266],"regimen,":[267],"along":[268],"that":[275],"did":[276],"not":[277],"reach":[278],"statistical":[279],"significance.":[280]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}